1.2000
+0.0250
+(2.13%)
At close: January 17 at 3:39:55 PM GMT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-10,434.9980
-10,434.9980
-12,258.0310
-12,250.4670
-5,794.6980
Investing Cash Flow
219.9840
219.9840
-63.9460
-541.4540
-65.5310
Financing Cash Flow
-140.0420
-140.0420
147.6190
35,065.2070
10,181.0250
End Cash Position
6,171.6360
6,171.6360
16,454.2410
28,874.9080
6,282.6650
Capital Expenditure
-78.9150
-78.9150
-63.9460
-541.4540
-65.5310
Issuance of Capital Stock
18.0940
18.0940
267.2850
37,307.8960
10,725.7970
Free Cash Flow
-10,513.9130
-10,513.9130
-12,321.9770
-12,791.9210
-5,860.2290
12/31/2020 - 3/29/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NCYT.L Novacyt S.A.
56.70
-3.90%
IOB.DU Ion Beam Applications SA
12.98
-2.41%
2SE.F Sequana Medical NV
2.5400
-1.17%
NEOLA.ST Neola Medical AB (publ)
2.5400
-0.78%
8C4.F CYBERDYNE Inc.
1.0440
-0.19%
CYBQF CYBERDYNE Inc.
1.0350
0.00%
ABT.VI Abbott Laboratories
110.40
+0.84%
2SE.SG Sequana Medical NV
2.5400
-2.68%
EPIS-B.ST Episurf Medical AB (publ)
0.1318
-2.23%
ABL.SG Abbott Laboratories
110.38
+0.44%